{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:37:16Z","timestamp":1791722236594,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Clinical Specialty of Yancheng City, Jiangsu Province."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06952-8","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T17:55:41Z","timestamp":1747331741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between renal function and cognitive impairment in patients with stable schizophrenia: a multicenter cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Cong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"3","key":"6952_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"Y Huang","year":"2019","unstructured":"Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study [J]. Lancet Psychiat. 2019;6(3):211\u201324.","journal-title":"Lancet Psychiat"},{"issue":"2","key":"6952_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137\u201350.","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"6952_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","volume":"77","author":"RA Mccutcheon","year":"2020","unstructured":"Mccutcheon RA, Reis Marques T, Howes OD. Schizophrenia-An Overview [J]. Jama Psychiatry. 2020;77(2):201\u201310.","journal-title":"Jama Psychiatry"},{"issue":"3","key":"6952_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/0020764019897697","volume":"66","author":"AH Khalil","year":"2020","unstructured":"Khalil AH, El-Meguid MA, Bastawy M, et al. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia [J]. Int J Soc Psychiatry. 2020;66(3):240\u20138.","journal-title":"Int J Soc Psychiatry"},{"issue":"10323","key":"6952_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","volume":"399","author":"S Jauhar","year":"2022","unstructured":"Jauhar S, Johnstone M, McKenna PJ. Schizophrenia [J]. Lancet (London, England). 2022;399(10323):473\u201386.","journal-title":"Lancet (London, England)"},{"issue":"4","key":"6952_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jamapsychiatry.2019.3993","volume":"77","author":"AJ Fett","year":"2020","unstructured":"Fett AJ, Velthorst E, Reichenberg A, et al. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project [J]. JAMA Psychiat. 2020;77(4):387\u201396.","journal-title":"JAMA Psychiat"},{"issue":"7","key":"6952_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamapsychiatry.2022.1142","volume":"79","author":"K Jonas","year":"2022","unstructured":"Jonas K, Lian W, Callahan J, et al. The Course of General Cognitive Ability in Individuals With Psychotic Disorders [J]. JAMA Psychiat. 2022;79(7):659\u201366.","journal-title":"JAMA Psychiat"},{"key":"6952_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/NDT.S447965","volume":"20","author":"N Du","year":"2024","unstructured":"Du N, Meng X, Li J, et al. Decline in Working Memory in Stable Schizophrenia May Be Related to Attentional Impairment: Mediating Effects of Negative Symptoms, a Cross-Sectional Study [J]. Neuropsychiatr Dis Treat. 2024;20:149\u201358.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"6952_CR9","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.5498\/wjp.v14.i12.1804","volume":"14","author":"LJ Cui","year":"2024","unstructured":"Cui LJ, Cai LL, Na WQ, et al. Interaction between serum inflammatory cytokines and brain-derived neurotrophic factor in cognitive function among first-episode schizophrenia patients [J]. World J Psychiatry. 2024;14(12):1804\u201314.","journal-title":"World J Psychiatry"},{"key":"6952_CR10","doi-asserted-by":"publisher","first-page":"110668","DOI":"10.1016\/j.pnpbp.2022.110668","volume":"121","author":"SR Patlola","year":"2023","unstructured":"Patlola SR, Donohoe G, McKernan DP. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis [J]. Prog Neuropsychopharmacol Biol Psychiatry. 2023;121:110668.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"6952_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/brainsci13030490","volume":"13","author":"M Wiedlocha","year":"2023","unstructured":"Wiedlocha M, Zborowska N, Marcinowicz P, et al. Oxidative Stress Biomarkers among Schizophrenia Inpatients [J]. Brain Sci. 2023;13(3):490.","journal-title":"Brain Sci"},{"issue":"1","key":"6952_CR12","first-page":"4","volume":"11","author":"Z Peng","year":"2025","unstructured":"Peng Z, Jia Q, Mao J, et al. The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation [J]. Schizophrenia (Heidelberg, Germany). 2025;11(1):4.","journal-title":"Schizophrenia (Heidelberg, Germany)"},{"key":"6952_CR13","doi-asserted-by":"publisher","first-page":"950602","DOI":"10.3389\/fpsyt.2022.950602","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Sun X, Hu M, et al. Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study [J]. Front Psych. 2022;13:950602.","journal-title":"Front Psych"},{"key":"6952_CR14","doi-asserted-by":"publisher","first-page":"1013698","DOI":"10.3389\/fpsyt.2022.1013698","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H, Huang Z, Zhang X, et al. Association between lipid metabolism and cognitive function in patients with schizophrenia [J]. Front Psych. 2022;13:1013698.","journal-title":"Front Psych"},{"issue":"1","key":"6952_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12888-023-04533-1","volume":"23","author":"Z Li","year":"2023","unstructured":"Li Z, Zong X, Li D, et al. Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients [J]. BMC Psychiatry. 2023;23(1):45.","journal-title":"BMC Psychiatry"},{"issue":"21","key":"6952_CR16","doi-asserted-by":"publisher","first-page":"15624","DOI":"10.3390\/ijms242115624","volume":"24","author":"JL Andrews","year":"2023","unstructured":"Andrews JL, Zalesky A, Nair S, et al. Genetic and Epigenetic Regulation in Lingo-1: Effects on Cognitive Function and White Matter Microstructure in a Case-Control Study for Schizophrenia [J]. Int J Mol Sci. 2023;24(21):15624.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6952_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41380-021-01313-9","volume":"27","author":"I Khadimallah","year":"2022","unstructured":"Khadimallah I, Jenni R, Cabungcal JH, et al. Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia [J]. Mol Psychiatry. 2022;27(2):1192\u2013204.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"6952_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-024-03835-9","volume":"23","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wang W, Hei G, et al. Subgroups of cognitive impairments in schizophrenia characterized by executive function and their morphological features: a latent profile analysis study [J]. BMC Med. 2025;23(1):13.","journal-title":"BMC Med"},{"key":"6952_CR19","doi-asserted-by":"publisher","first-page":"1288955","DOI":"10.3389\/fpsyt.2024.1288955","volume":"15","author":"Y Liang","year":"2024","unstructured":"Liang Y, Shao R, Xia Y, et al. Investigating amplitude of low-frequency fluctuation and possible links with cognitive impairment in childhood and adolescence onset schizophrenia: a correlation study [J]. Front Psych. 2024;15:1288955.","journal-title":"Front Psych"},{"key":"6952_CR20","doi-asserted-by":"publisher","first-page":"106626","DOI":"10.1016\/j.nbd.2024.106626","volume":"200","author":"Q Yan","year":"2024","unstructured":"Yan Q, Liu M, Xie Y, et al. Kidney-brain axis in the pathogenesis of cognitive impairment [J]. Neurobiol Dis. 2024;200:106626.","journal-title":"Neurobiol Dis"},{"key":"6952_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3389\/fphar.2019.00932","volume":"10","author":"ESAC Sim\u00f5es","year":"2019","unstructured":"Sim\u00f5es ESAC, Miranda AS, Rocha NP, et al. Neuropsychiatric Disorders in Chronic Kidney Disease [J]. Front Pharmacol. 2019;10:932.","journal-title":"Front Pharmacol."},{"key":"6952_CR22","doi-asserted-by":"publisher","first-page":"103592","DOI":"10.1016\/j.ebiom.2021.103592","volume":"72","author":"X Chen","year":"2021","unstructured":"Chen X, Kong J, Pan J, et al. Kidney damage causally affects the brain cortical structure: A Mendelian randomization study [J]. EBioMed. 2021;72:103592.","journal-title":"EBioMed"},{"key":"6952_CR23","doi-asserted-by":"publisher","first-page":"1347682","DOI":"10.3389\/fneur.2024.1347682","volume":"15","author":"LY Wu","year":"2024","unstructured":"Wu LY, Lu YY, Zheng SS, et al. Associations between renal function, hippocampal volume, and cognitive impairment in 544 outpatients [J]. Front Neurol. 2024;15:1347682.","journal-title":"Front Neurol"},{"key":"6952_CR24","first-page":"912174241256164","volume":"60","author":"ST Chang","year":"2024","unstructured":"Chang ST, Liou JY, Wu BJ, et al. Prevalence and risk factors for chronic kidney disease among older adult patients with schizophrenia in Taiwan [J]. Int J Psychiatr Med. 2024;60:912174241256164.","journal-title":"Int J Psychiatr Med."},{"issue":"9","key":"6952_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.clinthera.2023.07.002","volume":"45","author":"M Oshima","year":"2023","unstructured":"Oshima M, Toyama T, Nakade Y, et al. Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study [J]. Clin Ther. 2023;45(9):889\u201393.","journal-title":"Clin Ther"},{"issue":"3","key":"6952_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2478\/jomb-2018-0031","volume":"38","author":"Z Catak","year":"2019","unstructured":"Catak Z, Kocdemir E, Ugur K, et al. A Novel Biomarker Renalase and Its Relationship with its Substrates in Schizophrenia [J]. J Med Biochem. 2019;38(3):299\u2013305.","journal-title":"J Med Biochem"},{"key":"6952_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/CLEP.S236885","volume":"12","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wen Z, Li Y, et al. Assessment Causality in Associations Between Serum Uric Acid and Risk of Schizophrenia: A Two-Sample Bidirectional Mendelian Randomization Study [J]. Clin Epidemiol. 2020;12:223\u201333.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"6952_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s43856-024-00467-1","volume":"4","author":"B Cheng","year":"2024","unstructured":"Cheng B, Bai Y, Liu L, et al. Mendelian randomization study of the relationship between blood and urine biomarkers and schizophrenia in the UK Biobank cohort [J]. Commun Med. 2024;4(1):40.","journal-title":"Commun Med"},{"key":"6952_CR29","doi-asserted-by":"publisher","first-page":"960059","DOI":"10.3389\/fphys.2022.960059","volume":"13","author":"C Zou","year":"2022","unstructured":"Zou C, Wang C, Lu L. Advances in the study of subclinical AKI biomarkers [J]. Front Physiol. 2022;13:960059.","journal-title":"Front Physiol"},{"key":"6952_CR30","doi-asserted-by":"publisher","first-page":"911968","DOI":"10.3389\/fendo.2022.911968","volume":"13","author":"Y Mei","year":"2022","unstructured":"Mei Y, Dong B, Geng Z, et al. Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights [J]. Front Endocrinol. 2022;13:911968.","journal-title":"Front Endocrinol"},{"issue":"8","key":"6952_CR31","doi-asserted-by":"publisher","first-page":"107632","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107632","volume":"33","author":"Y Ma","year":"2024","unstructured":"Ma Y, Chen Y, Yang T, et al. Blood biomarkers for post-stroke cognitive impairment: A systematic review and meta-analysis [J]. J Stroke Cerebrovasc Dis. 2024;33(8):107632.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"6952_CR32","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.5498\/wjp.v13.i12.1027","volume":"13","author":"Y Duan","year":"2023","unstructured":"Duan Y, Tang HX. Efficacy of enhanced extracorporeal counterpulsation combined with atorvastatin in the treatment of cognitive impairment after stroke [J]. World J Psychiatry. 2023;13(12):1027\u201336.","journal-title":"World J Psychiatry"},{"issue":"2","key":"6952_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg L, Hallstrom BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics [J]. Mol Cell Proteomics. 2014;13(2):397\u2013406.","journal-title":"Mol Cell Proteomics."},{"issue":"3","key":"6952_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/WNN.0000000000000100","volume":"29","author":"WD Hu","year":"2016","unstructured":"Hu WD, Chen J, Mao CJ, et al. Elevated Cystatin C Levels Are Associated with Cognitive Impairment and Progression of Parkinson Disease [J]. Cogn Behav Neurol. 2016;29(3):144\u20139.","journal-title":"Cogn Behav Neurol"},{"issue":"3","key":"6952_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-2010-101095","volume":"22","author":"R Ghidoni","year":"2010","unstructured":"Ghidoni R, Benussi L, Glionna M, et al. Plasma cystatin C and risk of developing Alzheimer\u2019s disease in subjects with mild cognitive impairment [J]. J Alzheimer\u2019s Dis. 2010;22(3):985\u201391.","journal-title":"J Alzheimer's Dis"},{"issue":"10","key":"6952_CR36","doi-asserted-by":"publisher","first-page":"e1497","DOI":"10.1038\/cddis.2014.459","volume":"5","author":"S Watanabe","year":"2014","unstructured":"Watanabe S, Hayakawa T, Wakasugi K, et al. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity [J]. Cell Death Dis. 2014;5(10):e1497.","journal-title":"Cell Death Dis"},{"key":"6952_CR37","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/NDT.S412825","volume":"19","author":"L Zuo","year":"2023","unstructured":"Zuo L, Dong Y, Pan Y, et al. Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack [J]. Neuropsychiatr Dis Treat. 2023;19:1543\u201354.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"6952_CR38","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nm.3898","volume":"21","author":"LK Smith","year":"2015","unstructured":"Smith LK, He Y, Park JS, et al. \u03b22-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis [J]. Nat Med. 2015;21(8):932\u20137.","journal-title":"Nat Med"},{"issue":"2","key":"6952_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.ackd.2008.01.010","volume":"15","author":"AM Murray","year":"2008","unstructured":"Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden [J]. Adv Chronic Kidney Dis. 2008;15(2):123\u201332.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"7","key":"6952_CR40","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1373\/clinchem.2005.049544","volume":"51","author":"DB Corlin","year":"2005","unstructured":"Corlin DB, Sen JW, Ladefoged S, et al. Quantification of cleaved beta2-microglobulin in serum from patients undergoing chronic hemodialysis [J]. Clin Chem. 2005;51(7):1177\u201384.","journal-title":"Clin Chem"},{"issue":"15","key":"6952_CR41","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1042\/CS20171028","volume":"131","author":"R Yang","year":"2017","unstructured":"Yang R, Fu S, Zhao L, et al. Quantitation of circulating GDF-11 and \u03b22-MG in aged patients with age-related impairment in cognitive function [J]. Clin Sci. 2017;131(15):1895\u2013904.","journal-title":"Clin Sci."},{"issue":"2","key":"6952_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00415-023-12056-8","volume":"271","author":"B Iazzolino","year":"2024","unstructured":"Iazzolino B, Grassano M, Moglia C, et al. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis [J]. J Neurol. 2024;271(2):955\u201361.","journal-title":"J Neurol"},{"key":"6952_CR43","doi-asserted-by":"publisher","first-page":"1378334","DOI":"10.3389\/fneur.2024.1378334","volume":"15","author":"RX Zhai","year":"2024","unstructured":"Zhai RX, Yu H, Ma H, et al. Progression of cognitive impairment in Parkinson\u2019s disease correlates with uric acid concentration [J]. Front Neurol. 2024;15:1378334.","journal-title":"Front Neurol"},{"key":"6952_CR44","doi-asserted-by":"publisher","first-page":"1123127","DOI":"10.3389\/fpsyt.2023.1123127","volume":"14","author":"Z Yuan","year":"2023","unstructured":"Yuan Z, Liu H, Zhang X, et al. Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period [J]. Front Psych. 2023;14:1123127.","journal-title":"Front Psych"},{"issue":"1","key":"6952_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","volume":"150","author":"R Tandon","year":"2013","unstructured":"Tandon R, Gaebel W, Barch DM, et al. Definition and description of schizophrenia in the DSM-5 [J]. Schizophr Res. 2013;150(1):3\u201310.","journal-title":"Schizophr Res"},{"issue":"3","key":"6952_CR46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00406-022-01492-8","volume":"273","author":"Y Yi","year":"2023","unstructured":"Yi Y, Huang Y, Jiang R, et al. The percentage and clinical correlates of alexithymia in stable patients with schizophrenia [J]. Eur Arch Psychiatry Clin Neurosci. 2023;273(3):679\u201386.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"6952_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.schres.2019.01.034","volume":"208","author":"C Shi","year":"2019","unstructured":"Shi C, Kang L, Yao S, et al. What is the optimal neuropsychological test battery for schizophrenia in China? [J]. Schizophr Res. 2019;208:317\u201323.","journal-title":"Schizophr Res"},{"key":"6952_CR48","doi-asserted-by":"publisher","first-page":"933642","DOI":"10.3389\/fpsyt.2022.933642","volume":"13","author":"S Ye","year":"2022","unstructured":"Ye S, Xie M, Yu X, et al. The Chinese Brief Cognitive Test: Normative Data Stratified by Gender, Age and Education [J]. Front Psych. 2022;13:933642.","journal-title":"Front Psych"},{"issue":"1","key":"6952_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.schres.2012.10.019","volume":"143","author":"J Jiang","year":"2013","unstructured":"Jiang J, Sim K, Lee J. Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population [J]. Schizophr Res. 2013;143(1):38\u201343.","journal-title":"Schizophr Res"},{"issue":"4","key":"6952_CR50","doi-asserted-by":"publisher","first-page":"386","DOI":"10.5152\/pcp.2021.21060","volume":"31","author":"L Li","year":"2021","unstructured":"Li L, Ma H, Wang X, et al. Validation of Chinese Version of Positive and Negative Syndrome Scale-6 in Clinical Setting: A Preliminary Study [J]. Psychiatr Clin Psychopharmacol. 2021;31(4):386\u201391.","journal-title":"Psychiatr Clin Psychopharmacol"},{"key":"6952_CR51","doi-asserted-by":"publisher","first-page":"753671","DOI":"10.3389\/fpubh.2021.753671","volume":"9","author":"X Hu","year":"2021","unstructured":"Hu X, Gu S, Zhen X, et al. Trends in Cognitive Function Among Chinese Elderly From 1998 to 2018: An Age-Period-Cohort Analysis [J]. Front Public Health. 2021;9:753671.","journal-title":"Front Public Health"},{"issue":"3","key":"6952_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/geronb\/gbx124","volume":"74","author":"Y Stephan","year":"2019","unstructured":"Stephan Y, Sutin AR, Terracciano A. Subjective Age and Cystatin C Among Older Adults [J]. J Gerontol B Psychol Sci Soc Sci. 2019;74(3):382\u20138.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"11","key":"6952_CR53","first-page":"2350","volume":"20","author":"XM Dong","year":"2016","unstructured":"Dong XM, Cai R, Yang F, et al. Predictive value of plasma \u03b22-microglobulin on human body function and senescence [J]. Eur Rev Med Pharmacol Sci. 2016;20(11):2350\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"6952_CR54","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s40520-019-01137-2","volume":"31","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhang H, Tian W, et al. Association between serum uric acid levels and coronary artery disease in different age and gender: a cross-sectional study [J]. Aging Clin Exp Res. 2019;31(12):1783\u201390.","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"6952_CR55","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/ije\/dyad043","volume":"52","author":"T Norris","year":"2023","unstructured":"Norris T, Salzmann A, Henry A, et al. The relationship between adiposity and cognitive function: a bidirectional Mendelian randomization study in UK Biobank [J]. Int J Epidemiol. 2023;52(4):1074\u201385.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"6952_CR56","doi-asserted-by":"publisher","first-page":"e6289","DOI":"10.1097\/MD.0000000000006289","volume":"96","author":"X Ying","year":"2017","unstructured":"Ying X, Jiang Y, Qin G, et al. Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population [J]. Medicine. 2017;96(10):e6289.","journal-title":"Medicine"},{"issue":"1","key":"6952_CR57","doi-asserted-by":"publisher","first-page":"2203516","DOI":"10.1080\/07853890.2023.2203516","volume":"55","author":"J Zhen","year":"2023","unstructured":"Zhen J, Liu S, Kam RYL, et al. Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population [J]. Ann Med. 2023;55(1):2203516.","journal-title":"Ann Med"},{"key":"6952_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2021.03.008","volume":"237","author":"M Etminan","year":"2021","unstructured":"Etminan M, Brophy JM, Collins G, et al. To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational Studies [J]. Am Heart J. 2021;237:62\u20137.","journal-title":"Am Heart J"},{"issue":"8","key":"6952_CR59","doi-asserted-by":"publisher","first-page":"e038247","DOI":"10.1136\/bmjopen-2020-038247","volume":"10","author":"M Hojlund","year":"2020","unstructured":"Hojlund M, Lund LC, Herping JLE, et al. Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study [J]. BMJ open. 2020;10(8):e038247.","journal-title":"BMJ open"},{"key":"6952_CR60","doi-asserted-by":"publisher","first-page":"1095923","DOI":"10.3389\/fphar.2022.1095923","volume":"13","author":"P Buttiker","year":"2022","unstructured":"Buttiker P, Weissenberger S, Esch T, et al. Dysfunctional mitochondrial processes contribute to energy perturbations in the brain and neuropsychiatric symptoms [J]. Front Pharmacol. 2022;13:1095923.","journal-title":"Front Pharmacol"},{"issue":"3","key":"6952_CR61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00005344-200109000-00005","volume":"38","author":"WS Waring","year":"2001","unstructured":"Waring WS, Webb DJ, Maxwell SR. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers [J]. J Cardiovasc Pharmacol. 2001;38(3):365\u201371.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"32","key":"6952_CR62","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, et al. Uric acid and oxidative stress [J]. Curr Pharm Des. 2005;11(32):4145\u201351.","journal-title":"Curr Pharm Des"},{"issue":"Pt 2","key":"6952_CR63","first-page":"377","volume":"132","author":"SM Euser","year":"2009","unstructured":"Euser SM, Hofman A, Westendorp RG, et al. Serum uric acid and cognitive function and dementia [J]. Brain. 2009;132(Pt 2):377\u201382.","journal-title":"Brain"},{"issue":"5","key":"6952_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.exger.2010.01.005","volume":"45","author":"J Li","year":"2010","unstructured":"Li J, Dong BR, Lin P, et al. Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians [J]. Exp Gerontol. 2010;45(5):331\u20135.","journal-title":"Exp Gerontol"},{"key":"6952_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jns.2017.01.071","volume":"375","author":"Y Wei","year":"2017","unstructured":"Wei Y, Wei YK, Zhu J. Early markers of kidney dysfunction and cognitive impairment among older adults [J]. J Neurol Sci. 2017;375:209\u201314.","journal-title":"J Neurol Sci"},{"issue":"2","key":"6952_CR66","first-page":"541","volume":"3","author":"S Gauthier","year":"2011","unstructured":"Gauthier S, Kaur G, Mi W, et al. Protective mechanisms by cystatin C in neurodegenerative diseases [J]. Front Biosci (Schol Ed). 2011;3(2):541\u201354.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"1","key":"6952_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12640-015-9522-3","volume":"28","author":"B Yang","year":"2015","unstructured":"Yang B, Zhu J, Miao Z, et al. Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke [J]. Neurotox Res. 2015;28(1):1\u20137.","journal-title":"Neurotox Res"},{"issue":"1","key":"6952_CR68","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12888-024-06335-5","volume":"24","author":"D Li","year":"2024","unstructured":"Li D, Huang Y, Lu H, et al. Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia [J]. BMC Psychiatry. 2024;24(1):912.","journal-title":"BMC Psychiatry"},{"issue":"6","key":"6952_CR69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/08039488.2014.1002420","volume":"69","author":"A Wysoki\u0144ski","year":"2015","unstructured":"Wysoki\u0144ski A, K\u0142oszewska I. Uric acid levels in patients with schizophrenia on clozapine monotherapy [J]. Nord J Psychiatry. 2015;69(6):453\u20138.","journal-title":"Nord J Psychiatry"},{"issue":"11","key":"6952_CR70","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","volume":"69","author":"M Tohen","year":"2008","unstructured":"Tohen M, Vieta E, Goodwin GM, et al. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study [J]. J Clin Psychiatry. 2008;69(11):1776\u201389.","journal-title":"J Clin Psychiatry"},{"key":"6952_CR71","first-page":"527","volume":"7","author":"N Vanwong","year":"2016","unstructured":"Vanwong N, Srisawasdi P, Ngamsamut N, et al. Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects [J]. Front Pharmacol. 2016;7:527.","journal-title":"Front Pharmacol"},{"issue":"2","key":"6952_CR72","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s12325-020-01566-w","volume":"38","author":"D Koller","year":"2021","unstructured":"Koller D, Almenara S, Mejia G, et al. Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics [J]. Adv Ther. 2021;38(2):1035\u201354.","journal-title":"Adv Ther."},{"issue":"1","key":"6952_CR73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13195-023-01217-6","volume":"15","author":"YM Huang","year":"2023","unstructured":"Huang YM, Ma YH, Gao PY, et al. Plasma \u03b2(2)-microglobulin and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in cognitively intact older adults: the CABLE study [J]. Alzheimer\u2019s Res Ther. 2023;15(1):69.","journal-title":"Alzheimer's Res Ther"},{"key":"6952_CR74","doi-asserted-by":"publisher","first-page":"1153439","DOI":"10.3389\/fnins.2023.1153439","volume":"17","author":"R Jia","year":"2023","unstructured":"Jia R, Yuan X, Zhang X, et al. Oxidative stress impairs cognitive function by affecting hippocampal fimbria volume in drug-na\u00efve, first-episode schizophrenia [J]. Front Neurosci. 2023;17:1153439.","journal-title":"Front Neurosci"},{"key":"6952_CR75","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12888-014-0268-x","volume":"14","author":"C Gonzalez-Liencres","year":"2014","unstructured":"Gonzalez-Liencres C, Tas C, Brown EC, et al. Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition [J]. BMC Psychiatry. 2014;14:268.","journal-title":"BMC Psychiatry"},{"key":"6952_CR76","doi-asserted-by":"publisher","first-page":"950960","DOI":"10.3389\/fphys.2022.950960","volume":"13","author":"J Shen","year":"2022","unstructured":"Shen J, Li Y, Jiao Y, et al. Wnt 3a Protects Myocardial Injury in Elderly Acute Myocardial Infarction by Inhibiting Serum Cystatin C\/ROS-Induced Mitochondrial Damage [J]. Front Physiol. 2022;13:950960.","journal-title":"Front Physiol"},{"issue":"6","key":"6952_CR77","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/01.pra.0000422741.95118.9f","volume":"18","author":"SH Preskorn","year":"2012","unstructured":"Preskorn SH. Clinically important differences in the pharmacokinetics of the ten newer \u201catypical\u201d antipsychotics: Part 3. Effects of renal and hepatic impairment [J]. J Psychiatr Pract. 2012;18(6):430\u20137.","journal-title":"J Psychiatr Pract."},{"issue":"10","key":"6952_CR78","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/j.ekir.2024.07.020","volume":"9","author":"EY Hernandez-Cruz","year":"2024","unstructured":"Hernandez-Cruz EY, Aparicio-Trejo OE, Hammami FA, et al. N-acetylcysteine in Kidney Disease: Molecular Mechanisms, Pharmacokinetics, and Clinical Effectiveness [J]. Kidney Int Rep. 2024;9(10):2883\u2013903.","journal-title":"Kidney Int Rep."},{"key":"6952_CR79","doi-asserted-by":"publisher","first-page":"128219","DOI":"10.3389\/fneur.2024.1282198","volume":"15","author":"F Vedaei","year":"2024","unstructured":"Vedaei F, Newberg AB, Alizadeh M, et al. Treatment effects of N-acetyl cysteine on resting-state functional MRI and cognitive performance in patients with chronic mild traumatic brain injury: a longitudinal study [J]. Front Neurol. 2024;15:128219.","journal-title":"Front Neurol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06952-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:04:15Z","timestamp":1747375455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06952-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6952"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06952-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5949938\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (Ethics Approval No. 2024027) was approved by the Ethics Committee of the Fourth People's Hospital of Yancheng City. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Research Committee and with the 1964 Helsinki declaration and its later amendments, or in accordance with comparable ethical standards. Informed consent was obtained from all participants. All enrolled patients signed an official written consent form that had been approved by the Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}